Source: https://www.law.cornell.edu/cfr/text/21/part-528
Timestamp: 2016-07-23 13:52:33
Document Index: 745025862

Matched Legal Cases: ['art 528', 'art 528', 'art 528', 'art 528', '§ 528', '§ 260', '§ 360', 'art 528']

21 CFR Part 528 - NEW ANIMAL DRUGS IN GENETICALLY ENGINEERED ANIMALS | US Law | LII / Legal Information Institute
CFR › Title 21 › Chapter I › Subchapter E › Part 528 21 CFR Part 528 - NEW ANIMAL DRUGS IN GENETICALLY ENGINEERED ANIMALS
There are 2 Updates appearing in the Federal Register for 21 CFR Part 528. View below or at eCFR (GPOAccess)
§ 528.1070 — Bc6 recombinant deoxyribonucleic acid construct.
74 FR 6823, Feb. 11, 2009, unless otherwise noted.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.United States CodeU.S. Code: Title 21 - FOOD AND DRUGS§ 260b§ 360b - New animal drugs
Title 21 published on 2015-04-01The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 21 CFR Part 528 after this date.2015-11-24; vol. 80 # 226 - Tuesday, November 24, 201580 FR 73104 - New Animal Drugs in Genetically Engineered Animals; opAFP-GHc2 Recombinant Deoxyribonucleic Acid Construct